Overview

The purpose of the present study is to conduct a two-arm Randomized Control Trial (RCT) comparing individuals receiving the 90Second Caregiver health letter, with a usual care (routine care received by caregivers) control group.

The goals of the present study are:

• To evaluate the effectiveness of the 90Second Caregiver health letter in improving caregiver's self-efficacy (primary outcome), savouring, and quality of life (secondary outcomes).
• To evaluate the effectiveness of the 90Second Caregiver health letter in reducing caregiver's psychological strain and caregiver burden (secondary outcomes).
• To examine the impact of levels of engagement with the 90Second Caregiver health letter on primary and secondary outcomes.
• To assess the usability of the 90Second Caregiver health letter, as it relates to the relevance of topic, user friendliness, and appropriateness of the readability levels.
• To evaluate psychometric properties of self-constructed measures in 90Second newsletter.

Eligibility

Inclusion Criteria:

• Participant is currently enrolled in the Caring Forward Trials within Cohort study (REB#1025253)
• Participant has agreed to be contacted for future studies by Dr. McGrath's staff
• Participant has agreed for their data to be used for future studies
• Participant has mild levels of distress, as indicated by mild scores on the DASS-21 and/or the ZBI-SF

Exclusion Criteria:

• Participant is NOT currently enrolled in the Caring Forward Trials within Cohort study (REB#1025253)
• Participant has NOT agreed to be contacted for future studies by Dr. McGrath's staff
• Participant has NOT agreed for their data to be used in future studies
• Participant does NOT report mild levels of distress, as indicated by mild scores on the DASS-21 and/or the ZBI-SF